ETR:DRW3

Drägerwerk AG & Co. KGaA - DRW3 Stock Forecast, Price & News

€40.95

+0.40 (+0.99%)

(As of 03/24/2023 12:00 AM ET)

Add

Compare

Today's Range: €40.30
▼
€40.95
50-Day Range: €39.65
▼
€43.90
52-Week Range: €38.20
▼
€53.05

Volume: 4,105 shs
Average Volume: 33,804 shs
Market Capitalization: $352.17 million

P/E Ratio: N/A
Dividend Yield: 0.46%
Price Target: €40.05

About Drägerwerk AG & Co. KGaA (ETR:DRW3) Stock

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.

Receive DRW3 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Drägerwerk AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

DRW3 Stock News Headlines

March 17, 2023 | americanbankingnews.com

Drägerwerk AG & Co. KGaA (ETR:DRW3) Given a €44.10 Price Target at Warburg Research

February 24, 2023 | seekingalpha.com

Fresenius Medical Care AG & Co. KGaA 2022 Q4 - Results - Earnings Call Presentation

March 26, 2023 | Behind the Markets (Ad)

BREAKING: Tiny biotech successfully treats blindness

There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.

February 24, 2023 | seekingalpha.com

Fresenius Medical Care AG & Co. KGaA (FMS) Q4 2022 Earnings Call Transcript

February 19, 2023 | marketwatch.com

Latest Waterborne Ink Market Research 2023-2027: Highlighting Rising Technology for Sustainable Growth

December 17, 2022 | morningstar.com

Draegerwerk AG & Co KGaA Pfd Shs - Non-voting

December 7, 2022 | finance.yahoo.com

Edited Transcript of DRWG.DE earnings conference call or presentation 28-Jul-22 1:00pm GMT

September 28, 2022 | finanznachrichten.de

DRAEGERWERK AG & CO KGAA ST

March 26, 2023 | Behind the Markets (Ad)

BREAKING: Tiny biotech successfully treats blindness

September 23, 2022 | finance.yahoo.com

Drägerwerk AG & Co. KGaA (DRW3.F)

September 22, 2022 | finanznachrichten.de

Aktueller Chart DRAEGERWERK AG & CO KGAA ST Aktie

September 7, 2022 | finance.yahoo.com

Edited Transcript of DRWG.DE earnings conference call or presentation 3-Mar-22 2:00pm GMT

July 29, 2022 | finanznachrichten.de

Drägerwerk Posts HY Loss

July 18, 2022 | finanznachrichten.de

Stark gegen den Strom… Warum am Montag eine Position?

July 15, 2022 | markets.businessinsider.com

Drägerwerk Q2 Preliminary Net Sales Down; Confirms FY Guidance

March 31, 2022 | finanznachrichten.de

Aktueller Chart DRAEGERWERK Aktie

January 16, 2022 | finanznachrichten.de

Drägerwerk mit guter operativer Entwicklung im Geschäftsjahr 2021

September 15, 2021 | wsj.com

Draegerwerk AG & Co. KGaA Pfd.

September 4, 2021 | finanznachrichten.de

DGAP-News: Börse Hannover: Rebalancing des Global Challenges Index - Drägerwerk AG & Co. KGaA neu im Nachhaltigkeitsindex

July 15, 2021 | nasdaq.com

Shares in Draegerwerk slide after disappointing Q2 results

June 17, 2021 | finance.yahoo.com

Drägerwerk AG & Co. KGaA (DGWPF)

June 8, 2021 | marketwatch.com

Respiratory Protective Equipment Market Research Business Opportunity, Global Trend, Future Growth, Key Findings and Forecast to 2027

May 3, 2021 | ca.finance.yahoo.com

Vital Signs Monitoring Device Market Research Report by Product, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

April 29, 2021 | nasdaq.com

Draegerwerk Posts Profit In Q1, Orders Down; Expects To Reach Or Exceed Upper End Of FY21 View Range

April 28, 2021 | marketwatch.com

Respiratory Protective Equipment Market to Hit $12.88 bn , Global Forecast Report 2027

April 15, 2021 | nasdaq.com

DAX Rises In Cautious Trade

April 13, 2021 | finance.yahoo.com

Gas Detection Equipment Market Value Projected To Reach US$ 5.6 Billion By 2027: Acumen Research And Consulting

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive DRW3 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Drägerwerk AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ETR
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: ETR:DRW3
CUSIP: N/A
CIK: N/A
Web: www.draeger.com
Phone: +49-451-8820
Fax: N/A
Employees: 14,910
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: €40.05
High Stock Price Forecast: €44.10
Low Stock Price Forecast: €36.00
Forecasted Upside/Downside: -2.2%
Consensus Rating: N/A
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): (€3.48)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 9.20
P/E Growth: 1.24
Net Income: $-64,560,000.00
Net Margins: -2.12%
Pretax Margin: N/A
Return on Equity: -4.93%
Return on Assets: -1.80%

Debt

Debt-to-Equity Ratio: 27.44
Current Ratio: 1.56
Quick Ratio: 0.81

Sales & Book Value

Annual Sales: $3.05 billion
Price / Sales: 0.12
Cash Flow: €11.42 per share
Price / Cash Flow: 3.59
Book Value: €70.26 per share
Price / Book: 0.58

Miscellaneous

Outstanding Shares: 8,600,000
Free Float: N/A
Market Cap: $352.17 million
Optionable: Not Optionable
Beta: -0.19

Key Executives

Mr. Stefan A. Drager B.A. (Age 59)
Chairman of the Exec. Board - Drägerwerk Verwaltungs AG
Comp: $2.06M

Mr. Gert-Hartwig Lescow (Age 55)
CFO, Exec. Board Member for IT & Vice Chairman of Exec. Board - Drägerwerk Verwaltungs AG
Comp: $1.35M

Mr. Anton Schrofner (Age 59)
Exec. Board Member for Medical Division - Drägerwerk Verwaltungs AG
Comp: $1.14M

Mr. Rainer Klug (Age 54)
Exec. Board Member for Safety Division - Drägerwerk Verwaltungs AG
Comp: $1.07M

Dr. Reiner Piske (Age 52)
Exec. Board Member for Sales & HR - Drägerwerk Verwaltungs AG
Comp: $1.15M

Stephan Kruse (Age 52)
Pres Bus. Unit Therapy, Medical Div. & Member of Supervisory Board
Comp: $40k

Thomas Fischler
Head of Treasury & Investor Relations

Mr. Welf Böttcher
Head of Corp. Communications

Key Competitors

View All Competitors

DRW3 Stock - Frequently Asked Questions

What is Drägerwerk AG & Co. KGaA's stock price forecast for 2023?: 0 Wall Street analysts have issued 1-year target prices for Drägerwerk AG & Co. KGaA's stock. Their DRW3 share price forecasts range from €36.00 to €44.10. On average, they anticipate the company's stock price to reach €40.05 in the next twelve months. This suggests that the stock has a possible downside of 2.2%.
View analysts price targets for DRW3 or view top-rated stocks among Wall Street analysts.
How have DRW3 shares performed in 2023?: Drägerwerk AG & Co. KGaA's stock was trading at €41.75 on January 1st, 2023. Since then, DRW3 shares have decreased by 1.9% and is now trading at €40.95.
View the best growth stocks for 2023 here.
Is Drägerwerk AG & Co. KGaA a good dividend stock?: Drägerwerk AG & Co. KGaA (ETR:DRW3) pays an annual dividend of €0.19 per share and currently has a dividend yield of 0.45%.
What other stocks do shareholders of Drägerwerk AG & Co. KGaA own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Drägerwerk AG & Co. KGaA investors own include ServiceNow (NOW), NVIDIA (NVDA), Skyworks Solutions (SWKS), Broadcom (AVGO), eBay (EBAY), Enterprise Products Partners (EPD), Tesla (TSLA), Verizon Communications (VZ), Advance Auto Parts (AAP) and Advanced Micro Devices (AMD).

What is Drägerwerk AG & Co. KGaA's stock symbol?: Drägerwerk AG & Co. KGaA trades on the ETR under the ticker symbol "DRW3."
What is Drägerwerk AG & Co. KGaA's stock price today?: One share of DRW3 stock can currently be purchased for approximately €40.95.
How much money does Drägerwerk AG & Co. KGaA make?: Drägerwerk AG & Co. KGaA (ETR:DRW3) has a market capitalization of $352.17 million and generates $3.05 billion in revenue each year. The company earns $-64,560,000.00 in net income (profit) each year or (€3.48) on an earnings per share basis.
How many employees does Drägerwerk AG & Co. KGaA have?: The company employs 14,910 workers across the globe.
How can I contact Drägerwerk AG & Co. KGaA?: Drägerwerk AG & Co. KGaA's mailing address is Moislinger Allee 53-55, LUEBECK, 23558, Germany. The official website for the company is www.draeger.com. The company can be reached via phone at +49-451-8820.

This page (ETR:DRW3) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial